AN ANTICANCER COMPOSITION
The present disclosure relates to an anticancer composition and a process for preparing the same. The present disclosure envisages an anticancer composition having urticic acid methyl ester, derived from Leucas linifolia, and at least one pharmaceutically acceptable carrier. The anticancer composition of the present disclosure can be used for treating breast cancer..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Europäisches Patentamt - (2018) vom: 08. März Zur Gesamtaufnahme - year:2018 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
RAI VAISHALI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2018-03-08, Last update posted on www.tib.eu: 2022-07-01, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
WO2018042323 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA010139117 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA010139117 | ||
| 003 | DE-627 | ||
| 005 | 20230503203626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA010139117 | ||
| 035 | |a (EPA)WO2018042323 | ||
| 035 | |a (EPA)61301347 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a RAI VAISHALI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a AN ANTICANCER COMPOSITION |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2018-03-08, Last update posted on www.tib.eu: 2022-07-01, Last updated: 2023-02-09 | ||
| 520 | |a The present disclosure relates to an anticancer composition and a process for preparing the same. The present disclosure envisages an anticancer composition having urticic acid methyl ester, derived from Leucas linifolia, and at least one pharmaceutically acceptable carrier. The anticancer composition of the present disclosure can be used for treating breast cancer. | ||
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a PAI VINITHA RAMANATH |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2018) vom: 08. März |
| 773 | 1 | 8 | |g year:2018 |g day:08 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/61301347/publication/WO2018042323A1?q=WO2018042323 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2018 |b 08 |c 03 |
| 951 | |a AR | ||
| 952 | |j 2018 |b 08 |c 03 | ||